心筋症(Cardiomyopathy):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016213)
◆英語タイトル:Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016213
◆発行日:2019年06月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥654,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[心筋症(Cardiomyopathy):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、心筋症(Cardiomyopathy)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・心筋症(Cardiomyopathy):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・心筋症(Cardiomyopathy)のフェーズ3治験薬の状況
・心筋症(Cardiomyopathy)治療薬の市場規模(販売予測)
・心筋症(Cardiomyopathy)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・心筋症(Cardiomyopathy)のフェーズ3治験薬分析
・開発中止中の心筋症(Cardiomyopathy)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cardiomyopathy Report is to understand the market and pipeline status of the drugs around the Cardiomyopathy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Cardiomyopathy. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Cardiomyopathy.
• A review of the marketed products under prescription for Cardiomyopathy, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Cardiomyopathy with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Cardiomyopathy drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Cardiomyopathy drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Cardiomyopathy drugs.
• Coverage of Cardiomyopathy Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for Cardiomyopathy
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Cardiomyopathy
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Cardiomyopathy
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• Cardiomyopathy Therapeutic Market, US, (Year), 2018
• Cardiomyopathy Marketed Drugs, API Manufacturers by US DMF Status, 2018
• Cardiomyopathy Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Drugs, API Manufacturers, Europe by Country, 2018
• Cardiomyopathy Drugs, API Manufacturers, India by State, 2018
• Cardiomyopathy Drugs, API Manufacturers, China by Province, 2018
• Cardiomyopathy Drugs, API Manufacturers by Geography 2018
• Cardiomyopathy Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for Cardiomyopathy, 2018
• Discontinued Drugs for Cardiomyopathy, 2018


List of Figures
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• Cardiomyopathy Therapeutic Market, US, (Year), 2018
• Cardiomyopathy Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• Cardiomyopathy Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Drugs, API Manufacturers, Europe by Country, 2018
• Cardiomyopathy Drugs, API Manufacturers, India by State, 2018
• Cardiomyopathy Drugs, API Manufacturers, China by Province, 2018
• Cardiomyopathy Drugs, API Manufacturers by Geography 2018
• Cardiomyopathy Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

心筋症(Cardiomyopathy)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 電気自動車用充電器の世界市場2018-2022
    About this market The focus of OEMs on connected EVs will drive growth in the market. The adoption rate of EVs by end-users is mainly restricted due to range anxiety. Many OEMS have started developing a connectivity module, which will be a standard unit in EVs to alleviate the problem shortly. Techn …
  • 世界のアリル系アルコール市場2017
    Allylic Alcohols Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germa …
  • 世界の低周波治療装置市場2015
    The Global Low frequency therapeutic apparatus Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Low frequency therapeutic apparatus industry. The report provides a basic overview of the industry including definitions, classifications, applications …
  • ガラスパッケージング整流ダイオードの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Glass Packaging Rectifier Diode Revenue, means the sales value of Glass Packaging Rectifier Diode This report studies sales (consumption) of Glass Packaging Rectifier Diode in Global market, especially in United States, China, Europe and Japan, focuses on top p …
  • 世界の真空 硬化炉市場:販売動向2018
    In this report, the global Vacuum Hardening Furnaces market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue …
  • アルコール誘導体の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Alcohol Derivative Revenue, means the sales value of Alcohol Derivative This report studies sales (consumption) of Alcohol Derivative in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with …
  • 世界及び中国の食物大豆繊維市場2017
    The 'Global and Chinese dietary soy fiber Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global dietary soy fiber industry with a focus on the Chinese market. The report provides key statistics on the market status of the dietary soy fibe …
  • 生体触媒作用・生体触媒の世界市場2016-2020
    About Biocatalysis and Biocatalysts Biocatalysis is a chemical process in which enzymes and other biological catalysts are used to speed up the reaction between organic components. These enzymes are derived from microorganisms or plant and animal cells. The use and penetration of biocatalysts are in …
  • 予備電力レンタルの世界市場
    About Standby Rental Power Rental power is used to meet peak load demand, base load supply, or as a standby. The need to provide uninterrupted power is a major factor that drives the growth of the global standby rental power market. A standby rental power system is a secondary electrical system that …
  • 拡張現実(AR)の世界市場:製品別(ヘッドマウントディスプレイ、ヘッドアップディスプレイ、ハンドヘルドデバイス)、用途別(小売、家電、自動車)、地域別予測
    Global Augmented Reality Market to reach USD 149 billion by 2025. Global Augmented Reality Market valued approximately USD 4.32 billion in 2017 is anticipated to grow with a healthy growth rate of more than 55.73% over the forecast period 2018-2025. The major driving factors that are concentrated wi …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016213 )"心筋症(Cardiomyopathy):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。